Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblasts.
Although long-term expression of therapeutic molecules is necessary for the treatment of permanent deficiencies, short-term expression of therapeutic molecules inducing local or systemic effects is preferable in clinical situations where temporary substitution is the goal. One such clinical setting is the administration of hematopoietic growth factors in cancer chemotherapy-induced myelosuppression. Several plasmid vectors containing the human granulocyte colony-stimulating factor (G-CSF) gene under transcriptional control of different regulatory elements were constructed. In vitro production of G-CSF by nonvirally transfected murine fibroblast clones initially increased after lethal irradiation and was detectable for at least 12 days. We also demonstrate that a single injection of irradiated G-CSF-secreting fibroblasts leads to accelerated hematopoietic recovery and mobilization of committed peripheral blood progenitor cells equivalent to that achieved by twice daily s.c. administration of high doses of recombinant human G-CSF. Using dicistronic vectors, high levels of G-CSF secretion were also obtained in human fibroblasts.
Rosenthal
F M
FM
Department of Medicine I (Hematology/Oncology), University Medical Center Freiburg, Germany.
Kulmburg
P
P
Früh
R
R
Pfeifer
C
C
Veelken
H
H
Mackensen
A
A
Köhler
G
G
Lindemann
A
A
Mertelsmann
R
R
D000818:Animals; D002478:Cells, Cultured; D003001:Cloning, Molecular; D005260:Female; D005347:Fibroblasts; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D016179:Granulocyte Colony-Stimulating Factor / Q000032:analysis / Q000235:genetics*; D006410:Hematopoiesis / Q000235:genetics* / Q000502:physiology; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D010957:Plasmids; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D014162:Transfection
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor